Skip to main content

Retinal Treatment on Detachment Industry Growth, Size and Technology Analysis

Global Retinal Detachment Industry Share Is Expected to Grow at The CAGR of ~5.9% During the Forecast Period and Is Estimated to Reach USD 2689.2 Million By 2023.Some of the key players in this market are: Carl Zeiss Meditec, Inc. (US), Centervue SpA (Italy), Co:Lab Pensacola (US), Eyenuk Inc (US), Imagine Eyes (France), HealPros, LLC (US), NEUROVISION IMAGING, LLC . (US), Optos (UK), Peek Vision Ltd. (UK), and others.

Retinal detachment is sever medical condition and medical emergency. Early diagnosis and treatment is very important to cure retinal detachment. Some of the common symptoms of retinal detachment are partial vision loss, blurred vision, suddenly seeing many floaters, and others. Retinal detachment can affect people of any age but it is more common in older adults aged from 60-70.

Changing technology is another important factor for the market growth. Introduction and rapid adoption of technologically advanced products are helping in effective diagnosis and treatment of retinal detachment.
Top players are mainly focusing on advanced product development by investing large amount of money in R&D for new product development as well as improvement of existing products.

Industry Segmentations  

Global Retinal Detachment Industry has been segmented on the basis of type which comprise of rhegmatogenous, tractional, exudativem, and others.

On the basis of diagnosis, it is segmented into retinal examination, imaging, fluorescein angiography, fundus photos, visual field test, and others. Imaging tests includes ultrasound and others. Ultrasound imaging is further sub-segmented into B-scan, A-Scan, and others.

On the basis of treatments, the market has been segmented into retinal tears, retinal detachment, and others. Retinal tears includes laser surgery (photocoagulation), freezing (cryopexy), and others. Retinal detachment is further sub-segmented into pneumatic retinopexy, scleral, vitrectomy, and others.

On the basis of end user, it is segmented into eye hospital and clinics, medical research centers, academic institutes, and others.

Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
…continued


Labels:

Comments

Post a Comment

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La Roche AG, Fibro
3 comments
Read more

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Regional Analysis, Competitive Landscape Forecast to 2023

Idiopathic Pulmonary Fibrosis Treatment is a life-threatening condition of the lungs in which tissues becomes thickened, stiff, and scarred over a long period. The IPF treatment market is driven by various factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, increasing geriatric population, along with the rising prevalence rates of IPF and other fibrotic diseases. Market Overview The high cost of surgery and the unavailability of proper treatment options are expected to curb the growth of the IPF treatment. The Global  Idiopathic Pulmonary Fibrosis Treatment Market  is expected to register a  CAGR of 12.3%  during the forecast period of 2019 to 2025, with a market value of USD 2,237 million in 2018. The global IPF treatment market is currently dominated by numerous market players. The key players are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in Sept
2 comments
Read more

Chatbots in Healthcare Market Research Report by Top Industry Vendors and Applications Scenario till 2023

Chatbots in Healthcare Market Overview Healthcare chatbots are programs which assist patients with queries. This reduces the burden on the clinical staff and lets them focus on their jobs. Automation of various workflow processes in the healthcare sector is likely to propel the demand for these virtual assistants. The global Chatbots in Healthcare Market is expected to touch USD 316.85 million by 2023 at 21.10% CAGR over the forecast period (2018-2023), as per Market Research Future (MRFR). It stood at USD 100.46 million in 2017. Rise of chronic diseases coupled with lack of medical experts to handle queries are main drivers of the market. For instance, cancer patients used chatbots to gain rapid assistance regarding medication and their adverse effects.  The  Chatbots in Healthcare Market   Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the  major players  such As,  Sensely, Inc. (U.S.), Your.MD (U.K.), Buoy Healt
2 comments
Read more